Industry Seeks Reforms To FDA Humanitarian Device Exemption Program
This article was originally published in The Gray Sheet
Executive SummaryAdvaMed is calling for legislative and regulatory reforms to the rare-disease-focused humanitarian device exemption FDA approval pathway
You may also be interested in...
More devices approved under a humanitarian device exemption could be priced for profit if draft Senate language is enacted, but restrictions are included to ensure that current pediatric incentives are not gutted.